Not a waste of time at all, just that many here have considered the evolving new approach being adopted by the FDA to among other consideration taking into account RWE.
I certainly hope that we are indeed awaiting Cures Act announcements to learn that Anavex will be one of the fist to take advantage.
Market Data 
Markets 
AI
